Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Reubi

Showing results (201-210 of 210) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 210 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1990
Receptor scintigraphy with a radioiodinated somatostatin analogue: radiolabeling, purification, biologic activity, and in vivo application in animalsW H Bakker, E P Krenning, W A Breeman, et al.
International Journal of Cancer|May 28, 1993
Somatostatin receptor-positive primary breast tumors: genetic, patient and tumor characteristicsA H Bootsma, C van Eijck, K K Schouten, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1991
In vivo use of a radioiodinated somatostatin analogue: dynamics, metabolism, and binding to somatostatin receptor-positive tumors in manW H Bakker, E P Krenning, W A Breeman, et al.
European Journal of Nuclear Medicine|August 1, 1993
Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patientsE P Krenning, D J Kwekkeboom, W H Bakker, et al.
Gut|January 1, 1996
Positive somatostatin receptor scintigraphy correlates with the presence of somatostatin receptor subtype 2M John, W Meyerhof, D Richter, et al.
The American Journal of Medicine|April 1, 1994
Somatostatin receptor scintigraphy: its value in tumor localization in patients with Cushing's syndrome caused by ectopic corticotropin or corticotropin-releasing hormone secretionW W de Herder, E P Krenning, C D Malchoff, et al.
The Journal of Clinical Endocrinology and Metabolism|December 1, 1994
[111In-DTPA-D-Phe1] octreotide scintigraphy in thyroidal and orbital Graves' disease: a parameter for disease activity?P T Postema, E P Krenning, R Wijngaarde, et al.
The Journal of Steroid Biochemistry and Molecular Biology|December 20, 1990
Prognostic value of pS2 protein and receptors for epidermal growth factor (EGF-R), insulin-like growth factor-1 (IGF-1-R) and somatostatin (SS-R) in patients with breast and ovarian cancerJ A Foekens, W L van Putten, H Portengen, et al.
Journal of Medicinal Chemistry|October 4, 2002
Potent and long-acting corticotropin releasing factor (CRF) receptor 2 selective peptide competitive antagonistsJ Rivier, J Gulyas, D Kirby, et al.
European Journal of Nuclear Medicine|November 1, 1996
Visualization of the thymus by substance P receptor scintigraphy in manP M van Hagen, W A Breeman, J C Reubi, et al.
Pageof 21

Showing results (201-210 of 210) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 210 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1990
Receptor scintigraphy with a radioiodinated somatostatin analogue: radiolabeling, purification, biologic activity, and in vivo application in animalsW H Bakker, E P Krenning, W A Breeman, et al.
International Journal of Cancer|May 28, 1993
Somatostatin receptor-positive primary breast tumors: genetic, patient and tumor characteristicsA H Bootsma, C van Eijck, K K Schouten, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1991
In vivo use of a radioiodinated somatostatin analogue: dynamics, metabolism, and binding to somatostatin receptor-positive tumors in manW H Bakker, E P Krenning, W A Breeman, et al.
European Journal of Nuclear Medicine|August 1, 1993
Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patientsE P Krenning, D J Kwekkeboom, W H Bakker, et al.
Gut|January 1, 1996
Positive somatostatin receptor scintigraphy correlates with the presence of somatostatin receptor subtype 2M John, W Meyerhof, D Richter, et al.
The American Journal of Medicine|April 1, 1994
Somatostatin receptor scintigraphy: its value in tumor localization in patients with Cushing's syndrome caused by ectopic corticotropin or corticotropin-releasing hormone secretionW W de Herder, E P Krenning, C D Malchoff, et al.
The Journal of Clinical Endocrinology and Metabolism|December 1, 1994
[111In-DTPA-D-Phe1] octreotide scintigraphy in thyroidal and orbital Graves' disease: a parameter for disease activity?P T Postema, E P Krenning, R Wijngaarde, et al.
The Journal of Steroid Biochemistry and Molecular Biology|December 20, 1990
Prognostic value of pS2 protein and receptors for epidermal growth factor (EGF-R), insulin-like growth factor-1 (IGF-1-R) and somatostatin (SS-R) in patients with breast and ovarian cancerJ A Foekens, W L van Putten, H Portengen, et al.
Journal of Medicinal Chemistry|October 4, 2002
Potent and long-acting corticotropin releasing factor (CRF) receptor 2 selective peptide competitive antagonistsJ Rivier, J Gulyas, D Kirby, et al.
European Journal of Nuclear Medicine|November 1, 1996
Visualization of the thymus by substance P receptor scintigraphy in manP M van Hagen, W A Breeman, J C Reubi, et al.
Pageof 21